CSI Singapore houses a full spectrum of basic and clinical translational facilities and anchors two strong multidisciplinary research programs, one in Cancer Stem Cells and Biology, and a second in Experimental Therapeutics. These research programs serve as platforms for our focus on key cancer disease areas such as gastric, liver, lung and leukemia, and are supported by robust investigational resources from our core facilities’ sophisticated technologies.